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L
ast summer ushered in a new era in the regulation of
chemicals. On 1 June 2007, REACH (Registration,
Evaluation, Authorisation and Restriction of
Chemicals), the expansive scheme by the European
Union (EU) to regulate chemicals used in commerce and
consumer products, took effect. REACH applies to
chemicals manufactured or marketed in Europe, and its
regulations affect companies exporting chemicals to
Europe as well as those located there. REACH puts the
burden on chemical companies to provide information
on how the chemicals they make affect human health
and the environment. REACH has two parts: the collec-
tion and sharing of data throughout supply chains, and
the authorization of chemicals of higher concern to
human and environmental health.
In an initiative that is set to be phased in over the
next 11 years, REACH will require the registration of
chemicals produced or marketed in the EU in quantities
of 1 metric ton or greater per year. Chemicals imported
or produced in amounts of 1,000 metric tons or more
are to be registered by November 2010, whereas those at
amounts of 1 metric ton or more are to be registered by
May 2018. 
“The basic philosophy of REACH is that the [chemi-
cal] industry is managing the risk, and what REACH
does is require the industry to put on paper the knowl-
edge about the chemicals they put on the market, and
describe how they are dealing with any possible risk
which might be in them,” says Joachim Kreysa, director
for cooperation at the European Chemicals Agency
(ECHA), which administers REACH.
Chemical companies have from 1 June 2008 until
30 November 2008 to pre-register so-called phase-in
substances—ones that are already marketed in the EU, or
that have been imported or made in the EU in the past
15 years even if not sold there—by providing ECHA
with such basic information as the name of the chemical
and the importer. “It is important that companies [out-
side Europe] begin to consider the possible impact of
REACH on their business now,” says Malachy
Hargadon, environmental counselor with the European
Commission, the executive branch of the 27-nation EU.
These companies should be examining their stock of
chemicals and the requirements of REACH, he adds.
Such chemicals are in a database called EINECS, or
European Inventory of Existing Chemical Substances.
Compliance Requirements
REACH requires safety and exposure data, including new
testing in some cases, on an estimated 30,000 chemicals
that will be sold in Europe. The extent of the data required
increases with increasing production volume. Compiling
that information is likely to be a mammoth task. “There’s
never been a data set compiled for this many chemicals like
this in history,” says Spencer Williams, a toxicologist at
ChemRisk, a Houston, Texas–based consulting firm that
is helping U.S. chemical companies understand what
REACH compliance involves. 
REACH also requires chemical manufacturers to sub-
mit a chemical safety report, or CSR, for the approximate-
ly one-third of chemicals that are imported or produced in
quantities greater than 10 metric tons per year. The goal of
the CSR is to understand the exposure scenario for each
use and demonstrate that these risks can be adequately
controlled. The CSR includes a human health and
environmental hazard assessment of a chemical and a
determination of how persistent and bioaccumulative it is.
The CSR must also include information on how the
chemical is used by downstream users—industries that use
the chemical in the products they make—and the risks for
different exposure scenarios. By the same token, REACH
requires the downstream user to give the chemical manu-
facturer enough information to allow it to assess the sub-
stance’s safety in the context of each use, or the user may
perform its own CSR. The result, says Charles Bartish,
director of product safety and regulatory compliance at gas
manufacturer Air Products and Chemicals, Inc., can be a
document of between 10 and 100 pages, which he says can
be a significant burden. REACH affects several hundred
chemicals that Air Products supplies to the industries the
company serves.
Different Effects for Different Companies
Williams says the impact of REACH spans a spectrum,
differentially affecting small and large companies and
requiring a significant commitment of skilled professionals.
Small companies may work hard to comply with REACH
information requirements, “but they’re going to be behind
the eight ball in comparison to their big competitors. Dow
[Chemical Company] has a number of people in-house, at
least eighteen that I’m aware of, who are hired to work on
REACH,” he says. Smaller companies, he says, are likely to
struggle because they simply lack the staff.
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involved in compliance, such as performing
cost–benefit analyses for chemicals (to deter-
mine whether it is worth the cost to register
chemicals with REACH), understanding the
supply chain (who gets what chemicals, how
are they used, etc.), gathering information
for the CSR, arranging for studies on expo-
sures to and hazards of chemicals, and gath-
ering information from existing studies on
exposure and hazard.
The U.S. Department of Commerce is
reaching out to help small and medium-sized
companies, says Rosemary Gallant, a
Brussels-based commercial attaché of the
department. “Our objective is to make sure
small and medium-sized exporters can stay in
the market. Our goal is to help them under-
stand what they need to know about
REACH, and make them aware of the time
frame for REACH,” she says. She notes that
some smaller U.S. exporters feel as though
they are being picked on by having to com-
ply with REACH requirements and are
unaware that REACH also applies to
European chemical companies as well.
Williams notes that REACH may mean
certain chemicals will no longer be used in
Europe. For example, he is familiar with one
company that is considering whether it is
even worthwhile to pre-register certain
chemicals that it sells in Europe; the costs in
terms of manpower and fees paid to ECHA
may simply not be worthwhile relative to the
amount of money the chemicals may earn. 
But Europe is a major market for chemi-
cal companies, says Geoffrey Bock, regional
sales manager for TÜVRheinland, a firm that
offers compliance help to companies affected
by REACH. According to the European
Commission, Europe is a €10 billion
(US$14 billion) economy representing
more than 490 million consumers. When
that is factored in, companies realize it is
worth the time and effort to comply with
REACH. “You have to remain competi-
tive,” Boc says.
Bartish notes that in spite of the amount
of information his company will have to sup-
ply to comply with REACH, it is not consid-
ering dropping any of the chemicals it makes
from European markets.
Some companies have expressed concern
about the substance information exchange
forum (SIEF) process that grows out of pre-
registering chemicals. ECHA will group
together companies who have pre-registered
similar substances. Those companies, many
of which are competitors, will have to work
together to provide much of the detailed
information required to actually register a
substance. 
Michael Walls, managing director of
health, products, and science policy at the
American Chemistry Council, claims this
process will force companies to share confi-
dential business information. Furthermore,
says U.S. Environmental Protection Agency
(EPA) policy advisor Christopher Blunck,
that agency would be able to use publicly
available data developed by chemical compa-
nies in its regulatory efforts. The EPA could
also gain access to confidential business infor-
mation submitted under REACH, says
Richard Denison, a senior scientist with the
Environmental Defense Fund. And unlike
the Toxic Substances Control Act, the U.S.
counterpart to REACH, the latter allows the
EU to share such information with other
national governments.
But Kreysa disputes that concern. “The
data exchange is one hundred percent con-
trolled by the companies themselves. We are
not forcing them to exchange anything that
is confidential,” he says. If the data exchange
cannot be done without providing confiden-
tial business information, he says, companies
can opt out provided they can justify their
reasons to ECHA.
Moreover, such groupings of chemical
companies are nothing new, says Denison.
The chemical industry has fostered these
groups to provide the EPA and the
Organisation for Economic Co-operation
and Development with testing and related
data under their programs that call for data
on high-production-volume chemicals (see
“GAO Sounds Off on Chemical Regulation,”
EHP 113:A828–A830 [2005]). “That is
essentially what the SIEFs are,” Denison says.
“They are an effort to try to ensure that we
don’t have duplicative or unnecessary testing
or requirements imposed.” 
Focus on Toxicity
REACH focuses regulatory attention on so-
called substances of very high concern, which
include those that are carcinogenic, muta-
genic, persistent, bioaccumulative, or toxic to
reproduction. They can also include other
substances for which there is “scientific evi-
dence of serious effects to human health and
the environment,” says Kreya. “This will be
determined on a case-by-case basis.” He adds
that substances of very high concern cannot
be marketed without specific authorization
from ECHA.
Walls finds REACH’s focus on these sub-
stances disturbing and somewhat misplaced,
arguing that the possibility of removing
chemicals from the market simply because of
their “hazard characteristics” is unnecessary.
The issue of importance, he says, is exposure,
not hazard in and of itself. “We use haz-
ardous chemicals everyday,” he says. 
But Denison argues that the distinction
between exposure and risk is not as clear as
Walls would have it. “Our ability to predict
exposure is notoriously bad,” he says. He
cites brominated flame retardants as an
example of a hazardous chemical to which
exposure was not predicted, yet the chemi-
cals are routinely found in humans and
wildlife. A June 2007 study in EHP reported
that neonatal exposure to the flame retar-
dant BDE-47 impaired the neurodevelop-
ment of mice.
Denison also argues that, even if a
chemical company is able to show there is
low exposure to a chemical in its production
facility, that chemical may be sold to cus-
tomers who may use it in ways that the
maker has no information about—a contin-
gency REACH attempts to address with its
CSR requirement. 
Walls acknowledges that the information
sharing promoted by REACH can be valu-
able, saying, “The responsibility to safely
manage chemicals is not just with the original
producer, it’s also with the downstream user.”
He adds, “REACH requires far more detailed
exposure information from downstream
users. The benefit of what REACH will do is
force us to understand nearly all the end-use
applications and see if there are any applica-
tions that cause us concern.” 
Kreysa notes that ECHA can grant
authorization to market a hazardous chemi-
cal if the company shows it can successfully
manage the risk by keeping exposure to a
minimum. But such authorization does have
limits. The most hazardous substances of
very high concern can be authorized only if
the applicant shows that the chemical’s bene-
fits outweigh its risks and that there are no
viable alternatives.
As for alternative chemicals, ECHA has
established committees to perform socio-
economic analyses of such replacements and
to consider risk management measures. These
committees “will deliver an opinion if these
measures are going to reduce the risk suffi-
ciently,” Kreysa says. Furthermore, permis-
sion to use such hazardous chemicals is
allowed only for specified time periods. “The
intention is that substances of very high con-
cern are to be replaced. But there is no auto-
matic deadline [for replacement],” he says.
Costs and Benefits of Compliance
According to an EU fee schedule issued late in
2007, standard costs for registering chemicals
are determined on a sliding scale, with
€31,000 (about US$45,000) currently the
cost of a chemical in the 1,000-metric-ton-or-
more group; the cost drops to €1,600
(US$2,300) for a substance in the 1- to 10-
metric-ton group. These fees are reduced for
small and medium companies. The cost of
applications for authorization of substances of
very high concern is expected to be around
€50,000 (US$72,000) for each use of the
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dossier will be several times that. 
Walls says these costs are a major con-
cern for companies. “What you’re talking
about is a significant financial incentive to
eliminate chemicals,” he says. Furthermore,
he argues the financial cost will interfere
with companies investing in innovation and
developing new products. 
This is completely untrue, counters
Denison: REACH actually decreases
requirements for registering new chemicals,
compared with prior EU rules, while signifi-
cantly increasing requirements for existing
chemicals. Denison says a major motivation
of REACH was to level the playing field
between new and existing chemicals—
precisely to remove the earlier disincentive
to introduce new chemicals.
Participants at a workshop on REACH
impact assessment, which was held
25–27 October 2004 and organized by the
Dutch presidency for the EU in The Hague,
acknowledged concerns about the legisla-
tion’s impact on innovation. Innovation
may be affected, concluded the workshop
summary report, The Impact of Reach,
“because available resources for research and
development might be used for the imple-
mentation of REACH,” particularly by
small, medium, and exporting companies.
But the workshop concluded that is only a
short-range impact. Moreover, the savings
in health were predicted to far outweigh
cost, and “in the longer perspective, the
requirements of REACH may stimulate the
development of less harmful substances as
substitutes for restricted ones.” 
Joel Tickner, a director at the Lowell
Center for Sustainable Production at the
University of Massachusetts Lowell, foresees
downstream users of chemicals forcing inno-
vation. “REACH will give users of chemi-
cals—companies that don’t really need [a
specific] chemical but its functionality—the
opportunity to push markets toward safer
chemistry,” he says. And he views the argu-
ment that REACH may stifle innovation as
specious: “If you look at the chemical uni-
verse right now, of the chemicals on the
market today, ninety-nine percent by vol-
ume were on the market in 1979.” 
In fact, Tickner argues, regulation can
actually drive innovation. He says there is a
clear interest of downstream users of chemi-
cals who want the functionality of the chem-
icals but not their toxicity. Companies in
sectors such as health care, footwear, elec-
tronics, and cleaning chemicals have already
started to demand these products from sup-
pliers. “REACH will provide important
information to help distinguish safer and
less safe chemicals,” Tickner says. He points
to the Green Chemistry and Commerce
Council, a network of companies dedicated
to green chemistry and sustainable design,
which has been working extensively to effec-
tively promote these concepts and whose
participants realize the critical importance of
REACH type data.
As a case in point, the EU’s July 2006 ban
on lead solder in electronics helped spur the
development of alternatives that don’t use
lead, says Raymond Lizotte, a product envi-
ronmental compliance engineer at American
Power Conversion Corporation in Massa-
chusetts. Fine-tuning alternatives can take
additional time. Still, Lizotte noted in the
December 2007 report CleanTech: An Agenda
for a Healthy Economy that his company had
been working to develop lead-free solder since
the early 1990s, with little to show for it until
the ban came about: “While our preceding
efforts allowed us to meet [the EU] deadlines
successfully, it’s hard to discount the role that
the regulatory requirement played in finally
bringing lead-free products to market.” 
Williams notes American chemical com-
panies “are not crazy about REACH,” but he
says they also recognize that it is a set of regu-
lations they have to live with if they wish to
do business in Europe. “That’s really been a
development in the last three or four months.
A lot of them are getting over their shock and
figuring out what needs to be done,” he says.
Tickner says the time spent by the U.S. gov-
ernment and the chemical industry arguing
against REACH has put U.S. companies sev-
eral years behind their European colleagues in
preparing for compliance, which could put
U.S. companies at a disadvantage.
At least one major player sees REACH as
potentially beneficial. Dow Chemical
Company stated on its “Dow and REACH”
website (http://www.dow.com/reach/) that
the new policy “represents a significant oppor-
tunity for chemicals manufacturers, their
suppliers, and customers to work together to
protect the environment and preserve the
future of the chemicals industry in Europe.”
Dow spokesman Mark Walton noted that the
information required by REACH would help
protect health and the environment by “help-
ing to identify and alleviate situations where
exposure to chemicals may be at levels that
should be reduced.” The overall impact of
REACH, according to Walton, would be a
“more favorable and sustainable business cli-
mate for Dow and the chemical industry.”
Kreysa expects the information required
by REACH to help ensure better public and
environmental health. “We will know a lot
more about the chemicals that are on the
market and the potential problems they
might pose,” he says. Because the firms that
are the final users of the chemical will know
much more, they will be able to better man-
age risk. “This should reduce the exposure
of humans and the environment to chemi-
cals that have negative effects,” he says. 
Denison says the information provided
by REACH should begin to help overcome
the difficulty in linking specific health prob-
lems with exposures to specific chemicals or
mixtures of chemicals. He says it’s important
to increase understanding of the hazards
posed by certain chemicals, and to take steps
to avoid exposing people to such chemicals.
“That’s what I think REACH is trying to
do,” he says. 
A Spreading Influence
REACH’s influence is not stopping with
chemical companies but is extending into
state governments in the United States. For
instance, Maine’s search for a more compre-
hensive way to regulate chemicals instead of
a substance-by-substance and use-by-use
approach was influenced by REACH, says
Ginger Jordan-Hillier, environmental public
health coordinator at the state’s Department
of Environmental Protection. An executive
order issued by Maine’s governor in
February 2006 established a task force to
come up with an overall policy requiring and
offering incentives to develop safe chemicals
in consumer products. 
And in August 2007, in what could be
thought of as a North American response to
REACH, the United States, Canada, and
Mexico signed an agreement in Montebello,
Québec, to assess 9,000 chemicals produced
or imported in volumes of 25,000 pounds or
more. The countries are required to com-
plete risk characterization on these chemcials
by 2012. By 2020 the countries must have
inventoried all chemicals currently used in
commerce. The agreement is aimed at shar-
ing information and coordinating risk man-
agement of the chemicals. 
In California, REACH is “definitely
being considered as a model” for chemical
regulation, says Denison, who is a scientific
advisor for the Green Chemistry Initiative,
an effort by the California Department of
Toxic Substances Control to promote green
chemistry and identify toxic substances. “I
think it can absolutely be said that the exis-
tence of REACH is influencing how
California and no doubt other states are
thinking about chemicals and chemicals poli-
cies,” says Denison.
REACH has, of course, just gone into
effect. It is less than a year old, and its ambi-
tious goals remain just that—goals. What
remains uncertain, and may so remain for
many years until REACH is fully implement-
ed, is whether the promise of improved risk
management of chemicals and improved envi-
ronmental and public health will be realized.
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